NL-OMON24347Not yet recruitingNot Applicable
Exploring bleeding risk and platelet function combined with multiple omics techniques in 22q11.2 deletion syndrome
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- one
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •-16 years or older.
- •-signed informed consent.
- •Adults with 22q11.2DS
- •-molecularly confirmed 22q11.2 deletion syndrome.
- •-Mentally competent (ability to give informed consent) and aged 16 years and older or, in case the individual is mentally incompetent aged 16 years and older, consent will be given by the legally authorized representative of the subject.
Exclusion Criteria
- •-The presence of any malignancy.
- •-Use of antiplatelet or anticoagulant drugs within the last two weeks prior to the study.
- •-Use of anti-inflammatory drugs within the last two weeks prior to the study.
- •- Medical history of auto-immune thrombocytopenia
- •Specific for healthy controls:
- •-A medical history of thrombocytopenia (<150.000 platelets per mL).
- •-Increased bleeding risk, defined as a diagnosed bleeding disorder.
- •-Metabolic disorder.
Investigators
Similar Trials
Recruiting
Not Applicable
Exploring bleeding risk and platelet function combined with multiple omics techniques in 22q11.2 deletion syndromeDiGeorge syndromeVelocardiofacial syndrome100355341008362410039628NL-OMON55192Medisch Universitair Ziekenhuis Maastricht60
Withdrawn
Not Applicable
thrombogenicity and platelet reactivity as risk factors for postoperative microemboli signals in patients undergoing carotid endarterectomystrokearteriosclerosis1000796310003216NL-OMON32409Academisch Ziekenhuis Maastricht100
Not yet recruiting
Not Applicable
Thrombogenicity and platelet reactivity as risk factors for postoperative microemboli signals in patients undergoing carotid endarterectomyNL-OMON25062MUMC100
Recruiting
Phase 4
To evaluate the effect of platelet&#45;rich plasma in bone healing of acute diaphyseal fractures of the tibiapatients who ere diagnosed as acute closed fracture of tibial shaft and underwent surgery with intramedullary nailplatelet-rich plasma, prp, tibia fracture, bone healing, cortex-to-callus ratio, biological augmentation, regenerative medicineTCTR20210220003H.R.H. Maha Chakri Sirindhorn Medical Center (MSMC)32
Completed
Not Applicable
Platelet Function in Hemodialysis PatientChronic Kidney DiseaseNCT02792283CHU de Reims100